ClinConnect ClinConnect Logo
Search / Trial NCT05485961

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis

Launched by CSL BEHRING · Aug 1, 2022

Trial Information

Current as of May 19, 2025

Recruiting

Keywords

End Stage Kidney Disease (Eskd) Myocardial Infarction (Mi) Atherosclerotic Cardiovascular Disease (Ascvd) Coronary Artery Disease Peripheral Artery Disease Diabetes

ClinConnect Summary

This clinical trial is studying a medication called CSL300 (Clazakizumab) to see if it can help improve heart health for adults with end-stage kidney disease (ESKD) who are undergoing dialysis. The trial is divided into two parts: the first part will help determine the best dose of CSL300, and the second part will look at how well it works in preventing heart problems and keeping patients safe. Participants in this study must be at least 18 years old, have been on dialysis for at least 12 weeks, and have certain health conditions like diabetes or heart disease.

If you join this trial, you will be randomly assigned to receive either the study medication or a placebo (a harmless version that looks like the real medication but has no active ingredients). Throughout the study, your health will be closely monitored to check for any side effects and to see how well the medication is working. It's important to know that if you have certain medical conditions or have taken specific medications recently, you may not be eligible to participate. This trial is currently recruiting participants, so if you think you might qualify, it could be a great opportunity to contribute to research that aims to improve treatment options for people with ESKD and heart disease.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Male or female at least 18 years of age
  • A diagnosis of ESKD undergoing maintenance dialysis for at least 12 weeks
  • Serum hs-CRP ≥ 2.0 mg/L
  • A diagnosis of diabetes mellitus OR ASCVD
  • Exclusion Criteria:
  • Subjects who participated in Part 1 (phase 2b) are not eligible to participate in Part 2 (phase 3)
  • Concomitant use of systemic immunosuppressant drugs
  • Abnormal LFTs
  • Any life-threatening disease expected to result in death within 12 months
  • A history of GI perforation, inflammatory bowel disease (except fully excised ulcerative colitis), or peptic ulcer disease
  • Clinically significant active infection or history of opportunistic or invasive fungal infection

About Csl Behring

CSL Behring is a global biotechnology leader focused on developing innovative therapies for patients with serious and rare diseases. As a subsidiary of CSL Limited, the company specializes in the research, development, and manufacture of life-saving biotherapies derived from human plasma. With a strong commitment to scientific excellence and patient care, CSL Behring conducts rigorous clinical trials to advance its portfolio of immunoglobulins, clotting factors, and other biopharmaceuticals. The organization aims to enhance the quality of life for patients worldwide while maintaining the highest standards of safety and efficacy in its products.

Locations

Hampton, Virginia, United States

Huntsville, Alabama, United States

Bakersfield, California, United States

Bakersfield, California, United States

Los Angeles, California, United States

Lynwood, California, United States

San Diego, California, United States

Victorville, California, United States

Lauderdale Lakes, Florida, United States

Miami, Florida, United States

Tampa, Florida, United States

Columbus, Georgia, United States

Roseville, Michigan, United States

Minneapolis, Minnesota, United States

Tupelo, Mississippi, United States

Kansas City, Missouri, United States

Portsmouth, New Hampshire, United States

Bronx, New York, United States

Durham, North Carolina, United States

Knoxville, Tennessee, United States

Hampton, Virginia, United States

Glendale, Arizona, United States

Phoenix, Arizona, United States

Tucson, Arizona, United States

Beverly Hills, California, United States

Chula Vista, California, United States

Glendale, California, United States

La Mesa, California, United States

La Palma, California, United States

Northridge, California, United States

San Diego, California, United States

San Jose, California, United States

Vacaville, California, United States

Denver, Colorado, United States

Bloomfield, Connecticut, United States

Middlebury, Connecticut, United States

Coral Gables, Florida, United States

Statesboro, Georgia, United States

Saint Clair Shores, Michigan, United States

Brookhaven, Mississippi, United States

North Platte, Nebraska, United States

College Point, New York, United States

Charlotte, North Carolina, United States

Greenville, North Carolina, United States

Bethlehem, Pennsylvania, United States

Columbia, South Carolina, United States

Spartanburg, South Carolina, United States

Norfolk, Virginia, United States

Sydney, New South Wales, Australia

Nambour, Queensland, Australia

Woolloongabba, Queensland, Australia

Clayton, Victoria, Australia

St Albans, Victoria, Australia

Aalst, , Belgium

Bonheiden, , Belgium

Gent, , Belgium

Leuven, , Belgium

Liège, , Belgium

Edmonton, Alberta, Canada

Kiel, , Germany

Villingen Schwenningen, , Germany

Montgomery, Alabama, United States

Garden Grove, California, United States

Riverside, California, United States

San Dimas, California, United States

Victorville, California, United States

Las Vegas, Nevada, United States

Houston, Texas, United States

San Antonio, Texas, United States

San Antonio, Texas, United States

Shenandoah, Texas, United States

Granada Hills, California, United States

Los Angeles, California, United States

Los Angeles, California, United States

San Dimas, California, United States

Coral Springs, Florida, United States

Hollywood, Florida, United States

Miami, Florida, United States

Orlando, Florida, United States

Winter Park, Florida, United States

Brunswick, Georgia, United States

Sioux City, Iowa, United States

Wichita, Kansas, United States

Pontiac, Michigan, United States

Minneapolis, Minnesota, United States

Lincoln, Nebraska, United States

Henderson, Nevada, United States

Austin, Texas, United States

Austin, Texas, United States

Dallas, Texas, United States

El Paso, Texas, United States

El Paso, Texas, United States

San Antonio, Texas, United States

Chesapeake, Virginia, United States

Glendale, Arizona, United States

La Mesa, California, United States

Oxnard, California, United States

Denver, Colorado, United States

Newark, Delaware, United States

Boca Raton, Florida, United States

Miami Lakes, Florida, United States

Temple Terrace, Florida, United States

Douglasville, Georgia, United States

Kalamazoo, Michigan, United States

Reno, Nevada, United States

Jersey City, New Jersey, United States

Raleigh, North Carolina, United States

Fort Worth, Texas, United States

Houston, Texas, United States

Houston, Texas, United States

Mcallen, Texas, United States

Fairfax, Virginia, United States

Bluefield, West Virginia, United States

Halifax, Nova Scotia, Canada

Kingston, Ontario, Canada

Kagoshima Shi, , Japan

Nagaoka Shi, , Japan

Oyama Shi, , Japan

Tsukuba Shi, , Japan

Ube Shi, , Japan

Yonago Shi, , Japan

Fullerton, California, United States

Fullerton, California, United States

Garden Grove, California, United States

Garden Grove, California, United States

Glendale, California, United States

La Palma, California, United States

Miami, Florida, United States

Louisville, Kentucky, United States

Baton Rouge, Louisiana, United States

Columbus, Mississippi, United States

Columbus, Ohio, United States

Houston, Texas, United States

San Antonio, Texas, United States

Ioánnina, , Greece

Thessaloniki, , Greece

Thessaloníki, , Greece

Thessaloníki, , Greece

Caserta, , Italy

Foggia, , Italy

Ichinomiya Shi, Aichi, Japan

Maebashi Shi, Gunma, Japan

Maebashi Shi, Gunma, Japan

Sapporo Shi, Hokkaido, Japan

Kusatsu Shi, Shiga, Japan

Hashima Gun, , Japan

Higashiosaka Shi, , Japan

Inashiki Gun, , Japan

Kurume Shi, , Japan

Kyoto Shi, , Japan

Nagoya Shi, , Japan

Nagoya, , Japan

Omihachiman, , Japan

Sakaimachi, , Japan

Takasaki Shi, , Japan

Braga, , Portugal

Oeiras, , Portugal

Uppsala, , Sweden

Tarzana, California, United States

Bronx, New York, United States

Urayasu Shi, Chiba Ken, Japan

Riverside, California, United States

Mishawaka, Indiana, United States

Eatontown, New Jersey, United States

Houston, Texas, United States

Saint Leonards, New South Wales, Australia

Wollongong, , Australia

Herlev, , Denmark

Kaiserslautern, , Germany

Ioánnina, , Greece

Rio, , Greece

Thessaloníki, , Greece

árta, , Greece

Ramat Gan, , Israel

Florence, , Italy

Pavia, , Italy

Rimini, , Italy

Kitakyushu Shi, Fukuoka, Japan

Shinjuku Ku, Tokyo, Japan

Kurume, , Japan

Yokohama Shi, , Japan

Constanta, , Romania

Bradford, , United Kingdom

Hamilton, Ontario, Canada

Oshawa, Ontario, Canada

Montreal, Quebec, Canada

Aalborg, , Denmark

Hillerød, , Denmark

Mainz, , Germany

Larissa, , Greece

H̱olon, , Israel

Petah Tikva, , Israel

Tel Aviv, , Israel

Brescia, , Italy

Peschiera Del Garda, , Italy

San Giovanni Rotondo, , Italy

Verona, , Italy

Hokkaido, , Japan

Hialeah Gardens, Florida, United States

Medley, Florida, United States

Cairns, Queensland, Australia

Murdoch, , Australia

Stara Zagora, , Bulgaria

London, Ontario, Canada

Amiens, , France

Caen, , France

Paris, , France

Toulouse, , France

Berlin, , Germany

Hessen, , Germany

Kistarcsa, , Hungary

Haifa, , Israel

Zefat, , Israel

Messina, , Italy

Prato, , Italy

Ilsan Gu, Seoul, Korea, Republic Of

Goyang Si, , Korea, Republic Of

Gwangju, , Korea, Republic Of

Seoul, , Korea, Republic Of

Bucuresti, , Romania

Satu Mare, , Romania

Londonderry, , United Kingdom

Stoke On Trent, , United Kingdom

Beaumont, Texas, United States

Lom, , Bulgaria

Toronto, , Canada

Strasbourg, , France

Heraklion, , Greece

Milano, , Italy

Seoul, , Korea, Republic Of

Bucharest, , Romania

Salinas, California, United States

Houston, Texas, United States

Southport, , Australia

Westmead, , Australia

Roeselare, , Belgium

Smolyan, , Bulgaria

Herning, , Denmark

Brest, , France

Saint Ouen, , France

Crete, , Greece

Thessaloníki, , Greece

Tiberias, , Israel

Anyang Si, , Korea, Republic Of

Daegu, , Korea, Republic Of

Gangnam Gu, , Korea, Republic Of

Wonju Si, , Korea, Republic Of

Porto, , Portugal

Coventry, , United Kingdom

Liverpool, , United Kingdom

London, , United Kingdom

Tarzana, California, United States

Hollywood, Florida, United States

Miami, Florida, United States

Albany, Georgia, United States

Kansas City, Missouri, United States

Mineola, New York, United States

Knoxville, Tennessee, United States

Mansfield, Texas, United States

La Louvière, , Belgium

Montréal, Quebec, Canada

Montréal, , Canada

Montréal, , Canada

Beijing, , China

Zhenjiang City, , China

Aura, , France

Limoges Cedex, , France

Montpellier, , France

Alexandroupolis, , Greece

Lecco, , Italy

Novara, , Italy

Loures, , Portugal

Lleida, , Spain

Derby, , United Kingdom

Salford, , United Kingdom

Wolverhampton, , United Kingdom

Patients applied

0 patients applied

Trial Officials

Study Director

Study Director

CSL Behring LLC

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials